Handbook of clinical nanomedicine: Law, business, regulation, safety, and risk

Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk

Volumn 2, Issue , 2016, Pages 1-1448

  Bawa, Raj ^a,b,c   Audette, Gerald F ^d   Reese, Brian E ^e  

^a Bawa Biotechnology Consulting LLC   (United States)

^b Research Rensselaer Polytechnic Institute   (United States)

^c TEVA PHARMACEUTICALS   (Israel)

^d YORK UNIVERSITY   (Canada)

^e Choate Hall and Stewart LLP ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL NANOTECHNOLOGY; MEDICINE; RISK ANALYSIS; RISK ASSESSMENT;

CRITICAL ISSUES; INTERDISCIPLINARY FIELDS; LEADING EXPERTS; MARKET INTRODUCTION; PATENT LAWS; PERSONALIZED MEDICINES; PRODUCT LIFE CYCLES;

LIFE CYCLE;

EID: 85015024917     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4032/9789814669238     Document Type: Book

References (0)